ITOC (iTonic Holdings) Research & Development: $0.46 Mil (TTM As of Dec. 2025)


ITOC iTonic Holdings Ltd ITOC
14 GF Score
Price $0.31
! 6 Warning Signs
View Full Analysis

What is iTonic Holdings Research & Development?

iTonic Holdings ITOC -1.29% 14 Research & Development is $0.46 Mil as of Dec. 2025. GuruFocus rates ITOC with a GF Score™ of 14/100. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. iTonic Holdings's Research & Development for the six months ended in Dec. 2025 was $0.42 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.46 Mil.

iTonic Holdings  (NAS:ITOC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

iTonic Holdings Research & Development Related Terms

iTonic Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for iTonic Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iTonic Holdings Research & Development Chart

iTonic Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.08 0.07 0.08 0.09 0.46

iTonic Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.05 0.05 0.04 0.42
ITOC
14GF Score
iTonic Holdings Ltd ITOC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iTonic Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.46 Mil mean?
iTonic Holdings (ITOC) has a Research & Development of $0.46 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on iTonic Holdings and its competitors.
Is iTonic Holdings' Research & Development too high?
iTonic Holdings' current Research & Development is $0.46 Mil. Overall, iTonic Holdings has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does iTonic Holdings' Research & Development compare to HSCS and FEED?
iTonic Holdings' Research & Development of $0.46 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on iTonic Holdings and its competitors. iTonic Holdings's current Research & Development is $0.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iTonic Holdings stock overvalued right now?
iTonic Holdings (ITOC) has a current Research & Development of $0.46 Mil. The current Research & Development is $0.46 Mil. iTonic Holdings' overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For iTonic Holdings (ITOC), the current Research & Development is $0.46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iTonic Holdings Business Description

Address No. 8 Beiyuan Xiaojie, Room 405, LongHu Hailanyinqing Industrial Park, Building 6, Chaoyang District, Beijing, CHN
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.
14GF Score

Get the complete analysis for ITOC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.31
Price